Drug regulator gives nod for conducting study on mixing Covaxin, Covishield

The Drugs Controller General of India (DCGI), country drug regulator, has granted permission for conducting a study on mixing doses of Covaxin and Covishield COVID-19 vaccines.

The study and its clinical trials will be conducted by Christian Medical College (CMC) in Tamil Nadu’s Vellore.

“Permission has been granted for a research study by CMC Vellore (Tamil Nadu) on mixing of vaccines doses,” NITI Aayog member (health) Dr VK Paul said during a press briefing on Tuesday.

Last month, an expert panel of DCGI had recommended conducting a study on mixing doses of Covishield and Covaxin vaccines.

The recommendation came after the CMC sought permission to conduct such study.

The Subject Expert Committee of the Central Drugs Standard Control Organisation (CDSCO) had recommended granting permission to CMC for conducting the Phase-4 clinical trial covering 300 healthy volunteers for mixing of doses of Covaxin and Covishield.

The panel had said that purpose of this study is to assess whether a person can be given two different vaccine shots — one each of Covishield and Covaxin — to complete the vaccination course.

Editor JK News Updates

Leave a Reply

Your email address will not be published. Required fields are marked *

Next Post

Over 53.24 crore COVID vaccine doses provided to states, UTs: Centre

Wed Aug 11 , 2021
More than 53.24 crore COVID-19 vaccine doses have been provided to states and UTs so far and a further 72,40,250 doses are in the pipeline, the Union Health Ministry said on Wednesday. Of this, the total consumption including wastage is 51,56,11,035 doses. Over 2.25 crore balance and unutilised COVID-19 vaccine […]

Breaking News

%d bloggers like this: